Prognostic value of lymphatic and blood vessel invasion in neuroendocrine tumors of the lung

American Journal of Surgical Pathology

Volumn 29, Issue 3, 2005, Pages 324-328

  Schmid, Katharina ^a,b   Birner, Peter ^a   Gravenhorst, Verena ^a   End, Adelheid ^a   Geleff, Silvana ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Lung; Lymphatic and blood vessel invasion; Neuroendocrine tumor; Podoplanin; Prognosis

Indexed keywords

CD34 ANTIGEN; PODOPLANIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD VESSEL; CANCER DIAGNOSIS; CANCER GRADING; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CAPILLARY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; LYMPH NODE METASTASIS; LYMPH VESSEL; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE TUMOR; PROGNOSIS; SCHOOL CHILD; TUMOR LOCALIZATION; VASCULAR TUMOR;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BLOOD VESSELS; CARCINOMA, NEUROENDOCRINE; CHILD; DISEASE-FREE SURVIVAL; ENDOTHELIUM, LYMPHATIC; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASM INVASIVENESS;

EID: 14644425274     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000149706.74216.b6     Document Type: Article

References (23)

1. Banerji S, Ni J, Wang SX, et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol. 1999;144:789-801.
2. Beasley MB, Thunnissen FB, Brambilla E, et al. Pulmonary atypical carcinoid: predictors of survival in 106 cases. Hum Pathol. 2000;31:1255-1265.
3. Birner P, Obermair A, Schindl M, et al. Selective immunohistochemical staining of blood and lymphatic vessels reveals independent prognostic influence of blood and lymphatic vessel invasion in early-stage cervical cancer. Clin Cancer Res. 2001;7:93-97.
4. Brechot JM, Chevret S, Charpentier MC, et al. Blood vessel and lymphatic vessel invasion in resected nonsmall cell lung carcinoma: correlation with TNM stage and disease free and overall survival. Cancer. 1996;78:2111-2118.
5. Breiteneder-Geleff S, Matsui K, Soleiman A, et al. Podoplanin, a novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis. Am J Pathol. 1997;151:1141-1152.
6. Breiteneder-Geleff S, Soleiman A, Kowalski H, et al. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol. 1999;154:385-394.
7. Dadras SS, Paul T, Bertoncini J, et al. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneus melanoma metastasis and survival. Am J Pathol. 2003;162:1951-1960.
8. Fina L, Molgaard HV, Robertson D, et al. Expression of the CD34 gene in vascular endothelial cells. Blood. 1990;75:2417-2426.
9. Fujisawa T, Yamaguchi Y, Saitoh Y, et al. Blood and lymphatic vessel invasion as prognostic factors for patients with primary resected nonsmall cell carcinoma of the lung with intrapulmonary metastases. Cancer. 1995;76:2464-2470.
10. Garcia-Yuste M, Matilla JM, Alvarez-Gago T, et al. Prognostic factors in neuroendocrine lung tumors: a Spanish multicenter study. Ann Thorac Surg. 2000;70:258-263.
11. Harpole DH, Feldman JM, Buchanan S, et al. Bronchial carcinoid tumors: a retrospective analysis of 126 patients. Ann Thorac Surg. 1992;54:50-55.
12. Jussila L, Valtola R, Partanen TA. et al. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelium growth factor receptor-3. Cancer Res. 1998;58:1599-1604.
13. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc. 1985;53:457-481.
14. Lantuejoul S, Moro D, Michalides RJ, et al. Neural cell adhesion molecules (NCAM) and NCAM-PSA expression in neuroendocrine lung tumors. Am J Surg Pathol. 1998;22:1267-1276.
15. Macchiarini P, Dulmet E, De Montpreville V, et al. Prognostic significance of peritumoral blood and lymphatic vessel invasion by tumor cells in T4 non-small cell lung cancer following induction therapy. Surg Oncol. 1995;4:91-99.
16. Schoppmann SF, Birner P, Stöckl J, et al. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol. 2002;161:947-956.
17. Schoppmann SF, Birner P, Studer P, et al. Lymphatic microvessel density and lymphovascular invasion assessed by anti-podoplanin immunostaining in human breast cancer. Anticancer Res. 2001;21:2351-2355.
18. Sleeman JP, Krishnan J, Kirkin V, et al. Markers for the lymphatic endothelium: in search of the holy grail? Microsc Res Tech. 2001;55:61-69.
19. Suzuki K, Nagai K, Yoshida J, et al. Conventional clinicopathologic prognostic factors in surgically resected non small cell lung carcinoma: a comparison of prognostic factors for each pathologic TNM stage based on multivariate analysis. Cancer. 1999;86:1976-1984.
20. Travis WD, Linnoila RI, Tsokos MG, et al. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma: an ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol. 1991;15:529-553.
21. Travis WD, Rush W, Flieder DB, et al. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol. 1998;22:934-944.
22. Williams CS, Leek RD, Robson AM, et al. Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancer. J Pathol. 2003;200:195-206.
23. Wilson BS, Lloyd RV. Detection of chromogranin in neuroendocrine cells with a monoclonal antibody. Am J Pathol. 1984;115:458-468.